tetano
Editor, Senior Moderator
Citation: Pyrc K, Stożek K, Wojcik K, Gawron K, Zeglen S, et al. (2012) Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens. PLoS ONE 7(3): e32582. doi:10.1371/journal.pone.0032582
Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens
Krzysztof Pyrc1#*, Karol Stożek1#, Krzysztof Wojcik2,4, Katarzyna Gawron1, Slawomir Zeglen3, Wojciech Karolak3, Jacek Wojarski3, Marek Ochman3, Magdalena Hubalewska-Mazgaj4, Grazyna Bochenek4, Marek Sanak4, Marian Zembala3, Andrzej Szczeklik4, Jan Potempa1,5
1 Microbiology Department, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland, 2 Division of Cell Biophysics, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland, 3 Department of Cardiac Surgery and Transplantology, Silesian Center for Heart Diseases, Zabrze, Poland, 4 Department of Medicine, Jagiellonian University Medical College, Krakow, Poland, 5 Oral Health and Systemic Disease Research Group, School of Dentistry, University of Louisville, Louisville, Kentucky, United States of America
Abstract Top
Rapid and accurate detection and identification of viruses causing respiratory tract infections is important for patient care and disease control. Despite the fact that several assays are available, identification of an etiological agent is not possible in ~30% of patients suffering from respiratory tract diseases. Therefore, the aim of the current study was to develop a diagnostic set for the detection of respiratory viruses with sensitivity as low as 1?10 copies per reaction. Evaluation of the assay using a training clinical sample set showed that viral nucleic acids were identified in ~76% of cases. To improve assay performance and facilitate the identification of novel species or emerging strains, cultures of fully differentiated human airway epithelium were used to pre-amplify infectious viruses. This additional step resulted in the detection of pathogens in all samples tested. Based on these results it can be hypothesized that the lack of an etiological agent in some clinical samples, both reported previously and observed in the present study, may result not only from the presence of unknown viral species, but also from imperfections in the detection methods used.
full article
http://www.plosone.org/article/info...osone/PLoSONE+(PLoS+ONE+Alerts:+New+Articles)
Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens
Krzysztof Pyrc1#*, Karol Stożek1#, Krzysztof Wojcik2,4, Katarzyna Gawron1, Slawomir Zeglen3, Wojciech Karolak3, Jacek Wojarski3, Marek Ochman3, Magdalena Hubalewska-Mazgaj4, Grazyna Bochenek4, Marek Sanak4, Marian Zembala3, Andrzej Szczeklik4, Jan Potempa1,5
1 Microbiology Department, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland, 2 Division of Cell Biophysics, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland, 3 Department of Cardiac Surgery and Transplantology, Silesian Center for Heart Diseases, Zabrze, Poland, 4 Department of Medicine, Jagiellonian University Medical College, Krakow, Poland, 5 Oral Health and Systemic Disease Research Group, School of Dentistry, University of Louisville, Louisville, Kentucky, United States of America
Abstract Top
Rapid and accurate detection and identification of viruses causing respiratory tract infections is important for patient care and disease control. Despite the fact that several assays are available, identification of an etiological agent is not possible in ~30% of patients suffering from respiratory tract diseases. Therefore, the aim of the current study was to develop a diagnostic set for the detection of respiratory viruses with sensitivity as low as 1?10 copies per reaction. Evaluation of the assay using a training clinical sample set showed that viral nucleic acids were identified in ~76% of cases. To improve assay performance and facilitate the identification of novel species or emerging strains, cultures of fully differentiated human airway epithelium were used to pre-amplify infectious viruses. This additional step resulted in the detection of pathogens in all samples tested. Based on these results it can be hypothesized that the lack of an etiological agent in some clinical samples, both reported previously and observed in the present study, may result not only from the presence of unknown viral species, but also from imperfections in the detection methods used.
full article
http://www.plosone.org/article/info...osone/PLoSONE+(PLoS+ONE+Alerts:+New+Articles)